Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Right on the money - Q409 and Full year 2009 Revenue and EPS Review

|Includes: Gilead Sciences, Inc. (GILD)

Here is my projection almost 3 months ago that no one pays attention(Before analysts upgraded their Q409 estimates). Read on:
My projection
Q409 Rev 2.03B v 1.43B(+42%) EPS .88 v .60(+47%)
2009 Rev 7.01B v 5.34B(+31%) EPS 2.84 v 2.1(+35%)
Actual
Q409 Rev 2.03B v 1.43B(+42%) EPS .87 v .59(+47%)
2009 Rev 7.01B v 5.34B(+31%) EPS 2.82 v 2.06(+37%)

Notice my quarterly revenue estimate is exactly correct, while my EPS estimate is off by a penny. Percentage increase in my quarterly revenue estimate was incorrectedly stated as 36% instead of 42% as reported.  Please visit
messages.finance.yahoo.com/Stocks_(A_to_...
 

 

Disclosure: No Position